Keystone Financial Group (Kentucky)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.14M | Buy |
76,033
+8,124
| +12% | +$216K | 0.15% | 124 |
|
|
2025
Q4 | $1.69M | Sell |
67,909
-16,308
| -19% | -$411K | 0.13% | 119 |
|
|
2025
Q3 | $2.15M | Sell |
84,217
-10,989
| -12% | -$271K | 0.16% | 97 |
|
|
2025
Q2 | $2.31M | Buy |
95,206
+5,484
| +6% | +$128K | 0.21% | 86 |
|
|
2025
Q1 | $2.27M | Buy |
89,722
+20,039
| +29% | +$524K | 0.23% | 88 |
|
|
2024
Q4 | $1.85M | Sell |
69,683
-461
| -0.7% | -$12.5K | 0.18% | 97 |
|
|
2024
Q3 | $2.03M | Buy |
70,144
+9,572
| +16% | +$279K | 0.26% | 71 |
|
|
2024
Q2 | $1.69M | Buy |
60,572
+8,448
| +16% | +$233K | 0.61% | 32 |
|
|
2024
Q1 | $1.45M | Buy |
52,124
+14,215
| +37% | +$394K | 0.21% | 83 |
|
|
2023
Q4 | $1.09M | Buy |
37,909
+3,539
| +10% | +$107K | 0.19% | 85 |
|
|
2023
Q3 | $1.14M | Buy |
34,370
+2,137
| +7% | +$75.6K | 0.19% | 92 |
|
|
2023
Q2 | $1.18M | Buy |
+32,233
| New | +$1.25M | 0.2% | 91 |
|
|
2022
Q4 | $1.44M | Sell |
28,183
-111
| -0.4% | -$5.32K | 0.29% | 73 |
|
|
2022
Q3 | $1.24M | Buy |
28,294
+1,040
| +4% | +$50.5K | 0.25% | 84 |
|
|
2022
Q2 | $1.43M | Sell |
27,254
-17
| -0.1% | -$866 | 0.28% | 81 |
|
|
2022
Q1 | $1.41M | Buy |
27,271
+1,673
| +7% | +$86.8K | 0.24% | 83 |
|
|
2021
Q4 | $1.51M | Buy |
25,598
+3,976
| +18% | +$197K | 0.25% | 83 |
|
|
2021
Q3 | $930K | Buy |
21,622
+390
| +2% | +$17.3K | 0.17% | 109 |
|
|
2021
Q2 | $831K | Buy |
21,232
+202
| +1% | +$7.86K | 0.15% | 123 |
|
|
2021
Q1 | $762K | Buy |
21,030
+1,330
| +7% | +$47.2K | 0.15% | 124 |
|
|
2020
Q4 | $725K | Buy |
19,700
+75
| +0.4% | +$2.75K | 0.15% | 122 |
|
|
2020
Q3 | $683K | Buy |
19,625
+1,106
| +6% | +$38.8K | 0.17% | 118 |
|
|
2020
Q2 | $575K | Buy |
18,519
+107
| +0.6% | +$3.63K | 0.16% | 121 |
|
|
2020
Q1 | $570K | Buy |
18,412
+2,149
| +13% | +$73.2K | 0.19% | 105 |
|
|
2019
Q4 | $605K | Buy |
16,263
+405
| +3% | +$14.4K | 0.16% | 112 |
|
|
2019
Q3 | $541K | Sell |
15,858
-513
| -3% | -$18.7K | 0.17% | 114 |
|
|
2019
Q2 | $673K | Buy |
16,371
+293
| +2% | +$11.6K | 0.22% | 100 |
|
|
2019
Q1 | $648K | Buy |
16,078
+846
| +6% | +$33.9K | 0.23% | 100 |
|
|
2018
Q4 | $631K | Sell |
15,232
-343
| -2% | -$14.2K | 0.29% | 92 |
|
|
2018
Q3 | $654K | Buy |
15,575
+4,335
| +39% | +$167K | 0.27% | 96 |
|
|
2018
Q2 | $387K | Sell |
11,240
-303
| -3% | -$10.4K | 0.22% | 103 |
|
|
2018
Q1 | $384K | Buy |
11,543
+495
| +4% | +$17K | 0.21% | 96 |
|
|
2017
Q4 | $382K | Buy |
+11,048
| New | +$377K | 0.24% | 78 |
|
Other funds holding PFE
VCM
VPM
Keystone Financial Group (Kentucky)'s PFE Position: Q1 2026 in Review
Keystone Financial Group (Kentucky) increased its Pfizer (PFE) stake by 12% in Q1 2026, buying an estimated $216K and bringing the position to 76,033 shares worth $2.14M. The position accounts for 0.15% of the portfolio, ranked #124.
Keystone Financial Group (Kentucky) first reported a position in PFE in Q4 2017 and has held it in 33 quarters since. The position peaked at $2.31M in Q2 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Keystone Financial Group (Kentucky) held 76,033 shares of Pfizer worth $2.14M as of Q1 2026.
- Keystone Financial Group (Kentucky) bought 8,124 Pfizer shares in Q1 2026, an estimated $216K.
- Pfizer made up 0.15% of Keystone Financial Group (Kentucky)'s portfolio in Q1 2026, its #124 holding.
- Keystone Financial Group (Kentucky) first reported a position in Pfizer in Q4 2017 and has held it in 33 quarters since.
- Keystone Financial Group (Kentucky)'s Pfizer position peaked at $2.31M in Q2 2025.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Keystone Financial Group (Kentucky)'s 13F filing for Q1 2026, filed 13 May 2026.